Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT00093990 · COMPLETED
Trial details
- NCT number
- NCT00093990
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.